Jubilant Life Sciences’ arm Jubilant Biosys gets milestone payment from AstraZeneca

23 Jun 2011 Evaluate

Jubilant Life Sciences’ unit Jubilant Biosys has received an undisclosed amount as a milestone payment from AstraZeneca for its research on pain management in the neuroscience therapeutic area.

The alliance between Jubilant and London-headquartered drug firm AstraZeneca in the neuroscience therapeutic area began two years ago. Two years collaboration in neuroscience therapeutic area has now expanded to cardiovascular and metabolic diseases and focuses on the delivery of a steady stream of pre-clinical outcomes to AstraZeneca by Jubilant.

AstraZeneca owns the compounds developed under the collaboration with worldwide development and commercialization rights. On the other hand, Jubilant derives research funding and success-based development and commercialization milestone payments.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×